1. Home
  2. PLRX vs KG Comparison

PLRX vs KG Comparison

Compare PLRX & KG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.15

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

KG

Kestrel Group Ltd.

HOLD

Current Price

$6.27

Market Cap

87.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLRX
KG
Founded
2015
N/A
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
87.3M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
PLRX
KG
Price
$1.15
$6.27
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$2.67
N/A
AVG Volume (30 Days)
423.4K
38.4K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
29.97
1819.15
EPS
N/A
N/A
Revenue
N/A
$34,049,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
785.08
52 Week Low
$1.02
$6.24
52 Week High
$1.95
$29.13

Technical Indicators

Market Signals
Indicator
PLRX
KG
Relative Strength Index (RSI) 56.81 36.15
Support Level $1.12 N/A
Resistance Level $1.19 $8.23
Average True Range (ATR) 0.04 0.58
MACD 0.00 -0.05
Stochastic Oscillator 71.91 15.93

Price Performance

Historical Comparison
PLRX
KG

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

About KG Kestrel Group Ltd.

Kestrel Group Ltd specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers with two reportable segments: Program Services and Legacy Reinsurance. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.

Share on Social Networks: